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Abstract
Background: Therapeutic hypothermia has been proven to be effective in improving neurological outcome in
patients after cardiac arrest due to ventricular fibrillation (VF). Data concerning the effect of hypothermia treatment
on long-term survival however is limited.
Materials and methods: Clinical and outcome data of 107 consecutive patients undergoing therapeutic
hypothermia after cardiac arrest due to VF were compared with 98 historical controls. Neurological outcome was
assessed at ICU discharge according to the Pittsburgh cerebral performance category (CPC). A Kaplan-Meier analysis
of follow-up data concerning mortality after 24 months as well as a Cox-regression to adjust for confounders were
calculated.
Results: Neurological outcome significantly improved after mild hypothermia treatment (hypothermia group CPC
1-2 59.8%, control group CPC 1-2 24.5%; p < 0.01). In Kaplan-Meier survival analysis hypothermia treatment was
also associated with significantly improved 2-year probability for survival (hypothermia 55% vs. control 34%; p =
0.029). Cox-regression analysis revealed hypothermia treatment (p = 0.031) and age (p = 0.013) as independent
predictors of 24-month survival.
Conclusions: Our study demonstrates that the early survival benefit seen with therapeutic hypothermia persists
after two years. This strongly supports adherence to current recommendations regarding postresuscitation care for
all patients after cardiac arrest due to VF and maybe other rhythms as well.
Introduction
Patients surviving cardiac arrest still have a poor prog-
nosis with regard to both mortality and neurological
outcome. Current guidelines recommend mild hypother-
mia treatment after cardiac arrest due to ventricular
fibrillation (VF) as well as for other initial rhythms[1,2].
These recommendations are based on published data
demonstrating a significantly improved outcome with
therapeutic hypothermia, especially after VF cardiac
arrest. In these studies follow-up time ranged between 3
and 6 months[3,4].
Recent studies show that neurological performance does
not change markedly from the time of ICU discharge to
six months after cardiac arrest in the majority of patients
[5]. In a few patients functional outcomes improved over
time, while deterioration was rarely seen [6]. Mortality of
course is also an important factor when evaluating the
long-term effects of therapeutic hypothermia. Therefore
we have analyzed the probability of 2-year survival in a
cohort of patients undergoing therapeutic hypothermia
and compared these data to historical controls.
Materials and methods
The study protocol was approved by the local ethics
committee on human research. Between 2005 and 2007
a total of 107 patients were admitted consecutively to
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our MICU after in-hospital (IHCA) or out-of-hospital
cardiac arrest (OHCA). Hypothermia treatment was
applied to all survivors after cardiac arrest (n = 107) for
24 hours. A historical control group treated prior to the
implementation of hypothermia protocols was identified
(n = 98 patients admitted to our MICU between 2002
and 2004 after cardiac arrest). Detailed characteristics
for the study population are given in Table 1. All
patients received standard post resuscitation care which
did not undergo notable changes during the observation
period except for the application of therapeutic
hypothermia. In the treatment group hypothermia was
maintained for 24 hours using a surface cooling device
(ArcticSun2000® Medivance, USA).
Neurological outcome was defined at the time of dis-
charge from ICU according to the Pittsburgh cerebral
performance category (CPC) [7]. CPC 1 and 2 were clas-
sified as a favorable neurological outcome whereas CPC
3, 4 and 5 were regarded as an unfavorable outcome. A
follow-up concerning mortality was completed for all
patients after 24 months.
The SPSS software (Version 17.0) and Medcalc (Ver-
sion 11.0) were used for statistical analysis and graphical
depiction. Descriptive parameters are given as median
and interquartile range (25-75 percentiles). Univariate
analysis of differences between hypothermia patients
and the control group was performed by using the
Mann-Whitney-U test for non-parametric unpaired
data. Survival data were analyzed by the Kaplan-Meier
method and comparison between groups was performed
by the log-rank test. To adjust for confounders a Cox-
regression analysis was calculated.
Results
Study population
During the observation period, 107 consecutive coma-
tose patients after VF cardiac arrest were admitted to
our MICU. The baseline characteristics are given in
Table 1. Therapeutic hypothermia was initiated and
maintained for 24 hours in all of these patients without
any relevant complications. When comparing the
hypothermia patients with the historical control group
significant differences concerning epinephrine dosage (p
< 0.01), time to ROSC (p < 0.01), APACHE score at
admission (p = 0.02), rate of bystander CPR (p = 0.020)
and length of ICU-stay (LOS; p = 0.040) were found.
Neurological outcome
Data on neurological outcome of the patient groups at
ICU discharge is presented in Table 2. In the hypother-
mia group 64 patients (59.8%) were discharged with a
favorable neurological outcome whereas only 24 patients
(24.5%) of the control group had a good neurological
outcome. The difference between the groups was statis-
tically highly significant (p < 0.01).
In contrast CPC 5 was almost equally distributed
(hypothermia CPC 5 31.8%, control CPC 5 38.8%).
2-year survival
A follow-up concerning mortality was performed after
24 months. Six patients of the hypothermia group and
11 patients of the control group were lost to follow-up.
101 patients treated with therapeutic hypothermia and
87 control patients were included in this analysis.
The Kaplan-Meier analysis showed a significantly higher
2-year probability of survival in the hypothermia group
(hypothermia 55% vs. control 34%; p = 0.029; Figure 1).
Table 1 Baseline characteristics of the study population (n = 205)
Variable Control (n = 98) Hypothermia (n = 107) p-Value
Age (years) 64.5 (59.61-64.90) 60.5 (57.40-62.22) 0.13
Female sex-no./total no.(%) 26/98 (26.5) 26/107 (24.3) 0.71
APACHE Score 26 (24-27) 29 (27-29.) 0.02
Location of cardiac arrest
Out-of-hospital no./total-no. (%) 81 (82.7) 89 (83.2) 0.92
In-hospital no./total-no. (%) 17 (17.3) 18 (16.8)
Cause of cardiac arrest
AMI-no./total no. (%) 76 (77.6) 77 (72) 0.71
Primary arrhythmia-no./total-no. (%) 16 (16.3) 24 (22.4)
Respiratory-no./total-no. (%) 2 (2) 2 (1.9)
Other-no./total no.(%) 4 (4.1) 1 (0.9)
Time to ROSC (min) 22 (18-30) 19 (12-27.75) < 0.01
Total epinephrine dose (mg) 3 (2-6) 2.2 (0-5) < 0.01
Bystander CPR* 19 (24.3) 44 (99) 0.02
Length of ICU stay (days) 16 (13-21) 12 (9-16) 0.04
Time on ventilator (hours) 217 (180-313) 204 (145-243) 0.20
Data are presented as medians (25th and 75th percentiles) or as absolute numbers (relative frequencies). AMI - acute myocardial infarction, APACHE - acute
physiology and chronic health evaluation, ROSC - return of spontaneous circulation. * Bystander CPR; data are available from n = 78 in the control group and n =
106 in the hypothermia group.
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The hazard ratio for long-term mortality was calcu-
lated with HR = 1.55 (95% CI: 1.04-2.29).
Univariate analysis showed significant differences
between the groups for epinephrine dose, time to
ROSC, bystander CPR and APACHE-score. Therefore a
Cox-regression analysis was performed to adjust for
these possible confounders. Hypothermia treatment (p =
0.031) and age (p = 0.013) were the only parameters
identified as independent significant predictors for the
probability of 24-month survival (Table 3.).
Discussion
In our study we demonstrate a significantly improved 2-
year survival of patients treated with mild therapeutic
hypothermia after cardiac arrest compared to historical
controls. Our findings are in accordance with the
HACA trial which revealed a 14% lower mortality rate
after 6 months in the hypothermia group [8]. In contrast
long-term survival did not differ in a cohort of OHCA
patients treated with therapeutic hypothermia observed
by Bro-Jeppesen et al. [9]. This may be explained by a
remarkably low mortality in the control group. These
partly contradictory results emphasize limitations of an
observational study design. This also applies to our
results, we compared hypothermia patients with histori-
cal controls. Therefore it is possible that the improved
survival rate is associated with other changes in resusci-
tation practice as well. For example the rate of success-
ful resuscitation increased significantly between 1992
and 2005 in a large Swedish cohort probably due to an
increase in bystander CPR [10]. A similar tendency was
observed in our patient groups with significant differ-
ences regarding time to ROSC and epinephrine dosages
as probably major outcome determinants after cardiac
arrest [11]. To adjust for these confounders a Cox-
regression model was calculated, revealing hypothermia
treatment and age as independent predictors for prob-
ability of 24-month survival. Furthermore early cardiac
catheterization may have a major impact on outcome of
patients resuscitated from VF [12]. Additionally, local
treatment protocols may be an influence towards a
more sophisticated care of cardiac arrest survivors [13].
We found that significantly more patients were classi-
fied CPC 4 in the control group. During the observation
period the standard of postresuscitation care has not
been changed except for the implementation of the
hypothermia treatment protocol. Therefore this remark-
able difference in neurological outcome rather reflects
an effect of therapeutic hypothermia than posing a bias
to statistical analyses.
Furthermore time on ventilator and ICU stay were in
part significantly shorter under hypothermia treatment,
whereas distribution of mortality at ICU-discharge (CPC
5) was almost identical. Thus the outcome at ICU dis-
charge in both groups was probably not significantly
influenced by more early therapy withdrawal in the
treatment group. Nevertheless, neurological status may
influence the further development and therefore mortal-
ity of these patients. It cannot be fully excluded that




no./total-no. (%) (n = 98) (n = 107)
CPC 1 13 (13.3) 46 (43) < 0.01
CPC 2 11 (11.2) 18 (16.8)
CPC 3 10 (10.2) 4 (3.7)
CPC 4 26 (26.5) 4 (3.7)
CPC 5 38 (38.8) 34 (31.8)
CPC 1-2 24 (24.5) 64 (59.8)
CPC 3-5 74 (75.5) 42 (39.2) < 0.01
Neurological outcome assessed as cerebral performance category (CPC) at ICU
discharge. Data are presented as absolute numbers and relative frequencies.
Figure 1 Kaplan-Meier-survival analysis of both study groups.
A 2 year follow up was available for n = 101 in the hypothermia
group and n = 87 in the control group. The difference between the
two groups was significant (Logrank test p = 0.029).
Table 3 Cox-regression analysis
Variable Coefficient HR 95% CI p-Value
Epinephrine 0.039 1.04 0.980-1.103 0.198
Time to ROSC -0.002 1.00 0.977-1.019 0.856
Bystander CPR 0.190 1.21 0.857-1.707 0.280
Hypothermia -0.403 0.70 0.463-0.963 0.031
Age 0.018 1.02 1.004-1.032 0.013
Gender -0.076 0.93 0.623-1.378 0.706
APACHE 0.009 1.01 0.986-1.032 0.445
Regression coefficients, HR Hazard ratio, 95% CI confidence intervals, and P
values of Cox-regression model. Sign (- or +) indicates negative or positive
effect on the dependent variable. APACHE II, Acute Physiology and Chronic
Health Evaluation II; CI, confidence interval; bystander CPR, bystander
cardiopulmonary resuscitation; Time to ROSC, time to return of spontaneous
circulation.
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patients in a good condition are more likely to receive
sophisticated medical therapies than patients in persis-
tent coma. This may have also resulted in a higher
probability of survival in the treatment group which of
course can be only indirectly attributed to hypothermia
treatment. Reliable data concerning witnessed arrest and
a time delay to defibrillation which could also influence
survival are not available unfortunately.
In summary, it is known that the prognosis of patients
after out-of-hospital cardiac arrest is similar to that of
patients with acute myocardial infarction if they survive
until hospital discharge [14]. Our study demonstrates
that besides improved neurological outcome the early
survival benefit seen with therapeutic hypothermia per-
sists after two years. This should further encourage the
implementation of recommendations regarding postre-
suscitation care to all patients after cardiac arrest suffer-
ing from VF and maybe other rhythms as well.
Conclusion
In conclusion, our data demonstrate that therapeutic
hypothermia may be effective in two ways: First of all
the neurological outcome at ICU discharge is signifi-
cantly improved. Furthermore, there is a long lasting
benefit concerning probability of survival when thera-
peutic hypothermia has been applied.
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